Madrid Monitor

New: Use the 'Designation status' tab to easily check the status of protection of your international trademark registration in designated Madrid System Members; download unofficial certificates of protection; and more. Find out more and send us your feedback
Switch to the old version of Madrid Monitor.
 
 
 

International Trademark
 

1918509- BELKLIRIC
 
Trademark Holder Registration Date Expiration Date Nice classes
BELKLIRIC
Gilead Sciences Ireland UC
21.04.2026
21.04.2036
05
Printed : 10/03/2011
2026-05-07
732
Name and address of the holder of the registration
Gilead Sciences Ireland UC
IDA Business and Technology Park,
Carrigtohill
Co. Cork T45 DP77 (IE)
812
Contracting State or Contracting Organization in the territory of which the holder has a real and effective industrial or commercial establishment
IE
842
Legal nature of the holder (legal entity) and State, and, where applicable, territory within that State where the legal entity is organized
Private Unlimited Company, Ireland
740
Name and address of the representative
Gretchen R. Stroud
Gilead Sciences, Inc.,
333 Lakeside Drive
Foster City CA 94404 (US)
541
Reproduction of the mark where the mark is represented in standard characters
571
Description of the mark

WORD MARK.

511
International Classification of Goods and Services for the Purposes of the Registration of Marks (Nice Classification) - NCL(13-2026)
05

Pharmaceutical preparations.

821
Basic application
IE, 25.11.2025, 2025/02977
300
Data relating to priority under the Paris Convention and other data relating to registration of the mark in the country of origin

IE, 25.11.2025, 2025/02977

832
Designation(s) under the Madrid Protocol
AU - BR - CA - CH - CN - IL - IN - KR - MX - TR
527
Indications regarding use requirements
IN
Transaction History
 
International Registration, AU, BR, CA, CH, CN, IL, IN, KR, MX, TR  : 21.05.2026, 2026/19 Gaz 
151
Date of the registration
21.04.2026
450
Publication number and date
2026/19 Gaz, 21.05.2026 
832
Designation(s) under the Madrid Protocol
AU - BR - CA - CH - CN - IL - IN - KR - MX - TR
527
Indications regarding use requirements
IN
851
Limitation of the list of goods and services
CA
 
List limited to:
05

Pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases, disorders and infections; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; antiviral pharmaceutical preparations; antifungal pharmaceutical preparations; anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for autoimmune diseases and immunologic deficiency syndromes; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for the treatment of hepatitis; pharmaceutical preparations for the treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of herpes simplex virus infection; pharmaceutical preparations for treatment of metabolic conditions; pharmaceutical preparations for treatment of obesity; pharmaceutical preparations for endocrine diseases and disorders.

851
Limitation of the list of goods and services
IL
 
List limited to:
05

Pharmaceutical preparations, namely antiviral and anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the treatment of infectious conditions; pharmaceutical preparations for the treatment of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of oncology diseases and disorders; pharmaceutical preparations for treatment of metabolic conditions; pharmaceutical preparations for treatment of obesity; pharmaceutical preparations for endocrine diseases and disorders; pharmaceutical preparations for treatment of metabolic conditions; pharmaceutical preparations for treatment of obesity; pharmaceutical preparations for endocrine diseases and disorders.

581
Date of notification by the International Bureau to the designated Contracting Parties (from which the time limit to notify the refusal starts)
21.05.2026
270
Language of the application
English 
INITIAL_LINKS  : ..: After correction of .. 
 
1918509 

 

LOADING

International Trademark
 

Disclaimer: The registration of a mark in the International Register does not imply the expression of any opinion whatsoever on the part of the International Bureau of WIPO concerning the substance of the entitlement claim under the Madrid Protocol and its Regulations, or of the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.